IMMUTEP Ltd
IMMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506184
No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.
Other share classesPRRUF
13F holders, Q4 2022
Institutional positions in IMMUTEP Ltd as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +4 vs. Q3 2022
- Shares held
- 4.14M
- −1.19M (−22.2%) vs. Q3 2022
- Total value
- $7.25M
- −$1.06M (−12.8%) vs. Q3 2022
- New holders
- 7
- 3 more added
- Sold out
- 3
- 9 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $692.0K |
| Q1 2026 | 26 | $916.3K |
| Q4 2025 | 25 | $5.68M |
| Q3 2025 | 32 | $3.68M |
| Q2 2025 | 24 | $2.75M |
| Q1 2025 | 23 | $2.95M |
| Q4 2024 | 26 | $4.22M |
| Q3 2024 | 23 | $4.26M |
| Q2 2024 | 28 | $4.84M |
| Q1 2024 | 23 | $5.40M |
| Q4 2023 | 23 | $4.90M |
| Q3 2023 | 21 | $3.68M |
| Q2 2023 | 21 | $3.41M |
| Q1 2023 | 19 | $4.95M |
| Q4 2022 | 25 | $7.25M |
| Q3 2022 | 21 | $8.31M |
| Q2 2022 | 22 | $11.2M |
| Q1 2022 | 23 | $14.4M |
| Q4 2021 | 25 | $17.5M |
| Q3 2021 | 28 | $30.9M |
| Q2 2021 | 28 | $32.9M |
| Q1 2021 | 13 | $14.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding IMMUTEP Ltd; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 16 | $0 | 0.00% | +16 | New |
| Citigroup Inc | 58 | $102 | 0.00% | −3,937−98.5% | Reduced |
| National Bank of Canada | 300 | $525 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 700 | $1.23K | 0.00% | +700 | New |
| UBS Group AG | 1,353 | $2.37K | 0.00% | −9,232−87.2% | Reduced |
| Group One Trading, L.P. | 1,426 | $2.50K | 0.00% | +346+32.0% | Added |
| Simplex Trading, LLC | 2,514 | $4.00K | 0.00% | −8,364−76.9% | Reduced |
| Bank of America Corp | 2,567 | $4.49K | 0.00% | −7,827−75.3% | Reduced |
| Belpointe Asset Management LLC | 3,000 | $5.25K | 0.00% | +3,000 | New |
| Tower Research Capital LLC (TRC) | 7,401 | $13.0K | 0.00% | −7,800−51.3% | Reduced |
| HighTower Advisors, LLC | 10,000 | $18.0K | 0.00% | +10,000 | New |
| Virtu Financial LLC | 11,926 | $21.0K | 0.00% | +11,926 | New |
| Integrated Advisors Network LLC | 13,000 | $22.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 18,722 | $32.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 19,510 | $34.1K | 0.00% | −9,953−33.8% | Reduced |
| Old Mission Capital LLC | 21,158 | $37.0K | 0.00% | +21,158 | New |
| Jane Street Group, LLC | 21,785 | $38.1K | 0.00% | +21,785 | New |
| Verition Fund Management LLC | 35,000 | $61.3K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 65,834 | $115.2K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 71,115 | $124.0K | 0.00% | +2,729+4.0% | Added |
| Susquehanna International Group, LLP | 151,089 | $264.4K | 0.00% | +6,215+4.3% | Added |
| Morgan Stanley | 516,126 | $903.2K | 0.00% | −207,344−28.7% | Reduced |
| Millennium Management LLC | 727,552 | $1.27M | 0.00% | −340,915−31.9% | Reduced |
| Artal Group S.A. | 1,000,000 | $1.75M | 0.10% | 00.0% | Unchanged |
| Oracle Investment Management Inc | 1,442,325 | $2.52M | 2.20% | −115,000−7.4% | Reduced |
| BlackRock Inc. | 0 | $0 | 0.00% | −517,096−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −35,173−100.0% | Sold out |
| Pittenger & Anderson Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |